Format

Send to

Choose Destination
See comment in PubMed Commons below
Ann Dermatol Venereol. 2008 Feb;135 Suppl 4:S235-42. doi: 10.1016/S0151-9638(08)70541-6.

[Psoriasis, metabolic syndrome and its components].

[Article in French]

Author information

  • 1CHU de Nice, Service de Dermatologie, Hôpital 1'Archet 2, Avenue St Antoine de Ginestière, 06100 Nice, France. ortonne@unice.fr

Abstract

The psoriasis is a chronic dermatosis which is characterized by strong inflammation. Recent studies showed that the chronic inflammation plays an important part in the pathogenesis of many metabolic and vascular diseases. Moreover, the diseases mediated by lymphocytes TH1 were related to the myocardial infarction. Epidemiologic investigations showed that psoriasis is associated at the increased risk of Comorbidities and mortality per comparison to the general population. Thus, the psoriatic patients have a high prevalence of metabolic pathologies such as the diabetes, hypertension, obesity and hyperlipidemy. These concomitant affections can complicate the treatment of psoriasis. It is important that the dermatologist systematically seeks these concomitant pathologies among psoriatic patients. These data also suggest that the treatments of these patients improve not only the skin lesions, but also control the inflammation associated with the psoriasis.

PMID:
18466790
DOI:
10.1016/S0151-9638(08)70541-6
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Masson (France)
    Loading ...
    Support Center